Abstract

This chapter focuses on the adverse events termed as acute hemolytic reactions (AHTR) that occur during or following a transfusion. Transfusion of incompatible red blood cells (RBCs) or significant amounts of incompatible plasma, can lead to efficient antibody-antigen binding in the recipient that can activate the complement proteins and lead to intravascular hemolysis. The transfusion of incompatible RBCs is most associated with a mistransfusion event that occur due to incorrectly typed, labeled, crossmatched, issued or transfused to the incorrect patient. AHTR can occur from transfusion of ABO-incompatible blood as well as blood incompatible to other RBC antibodies. The transfusion of significant amounts of incompatible plasma occur less frequently and the passive transfer of donor high-titer anti-A or anti-B in plasma containing products results in hemolysis of the ABO-incompatible recipient's RBCs, which can cause severe morbidity and mortality. Transfusion of incompatible plasma most often occur in the administration of out-of-group platelets, most commonly group O platelets to a group A recipient, which not infrequently result in AHTR.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.